Christopher R. von Jako, PhD

Christopher von Jako

President and Chief Executive Officer

Dr. Christopher von Jako has served as President and Chief Executive Officer (CEO) since January 2020.

Chris is a technology-driven executive with 30 years of leadership and experience in the global medical device market. He is specifically passionate about the development and commercialization of minimally invasive techniques to improve health and transform lives. During his career, Chris led organizations to improve profitability, performance, and value in early-stage, expansion, turnaround, and Fortune 500 environments with five entities resulting in a merger or acquisition.

Most recently, Chris served as CEO of Dynatronics, a publicly traded medical device company that designs, manufactures, and sells high-quality restorative products. Prior to Dynatronics, he served as President and CEO of NinePoint Medical, a privately held medical device company that designs, manufactures, and sells an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology. Chris served as President and CEO of NeuroTherm, a privately held, minimally invasive interventional pain management company. In 2014, he successfully executed the divesture of NeuroTherm with his team to St. Jude Medical. He has also held leadership roles with other leading medical device companies, including Integra LifeSciences, Covidien, Medtronic, and Radionics.

Chris holds a PhD in Biomedical Sciences from the University of Pécs Medical School (Pécs, Hungary), an MS degree in Radiological Sciences and Technology from the Department of Nuclear Engineering at the Massachusetts Institute of Technology (Cambridge, Massachusetts), and a double BS degree in Physics and Mathematics from Bates College (Lewiston, Maine). Additionally, he has served on several boards throughout his career and currently serves as an independent director on the board of nView medical, Inc.